NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,265,501 | +199.7% | 167,801 | +379.6% | 0.00% | 0.0% |
| Q4 2022 | $1,423,218 | -47.9% | 34,990 | -37.6% | 0.00% | 0.0% |
| Q3 2022 | $2,731,000 | -14.0% | 56,090 | -15.7% | 0.00% | 0.0% |
| Q2 2022 | $3,174,000 | +7.5% | 66,517 | +63.5% | 0.00% | 0.0% |
| Q1 2022 | $2,952,000 | +136.9% | 40,680 | +171.3% | 0.00% | 0.0% |
| Q4 2021 | $1,246,000 | -46.6% | 14,996 | -23.5% | 0.00% | 0.0% |
| Q3 2021 | $2,334,000 | +88.1% | 19,609 | +164.9% | 0.00% | 0.0% |
| Q2 2021 | $1,241,000 | +62.6% | 7,402 | +41.4% | 0.00% | – |
| Q1 2021 | $763,000 | -52.4% | 5,236 | -44.7% | 0.00% | -100.0% |
| Q4 2020 | $1,602,000 | +112.2% | 9,473 | +76.7% | 0.00% | 0.0% |
| Q3 2020 | $755,000 | -44.2% | 5,361 | -54.6% | 0.00% | 0.0% |
| Q2 2020 | $1,353,000 | +839.6% | 11,808 | +681.5% | 0.00% | – |
| Q1 2020 | $144,000 | -74.6% | 1,511 | -68.7% | 0.00% | – |
| Q4 2019 | $568,000 | +97.9% | 4,827 | +44.7% | 0.00% | – |
| Q3 2019 | $287,000 | -14.6% | 3,337 | -35.6% | 0.00% | – |
| Q2 2019 | $336,000 | +342.1% | 5,183 | +327.3% | 0.00% | – |
| Q1 2019 | $76,000 | +26.7% | 1,213 | -21.8% | 0.00% | – |
| Q4 2018 | $60,000 | -88.0% | 1,551 | -82.3% | 0.00% | – |
| Q3 2018 | $498,000 | -78.4% | 8,752 | -69.7% | 0.00% | -100.0% |
| Q2 2018 | $2,303,000 | -24.3% | 28,846 | -17.9% | 0.00% | -33.3% |
| Q1 2018 | $3,044,000 | +68.1% | 35,128 | +33.9% | 0.00% | +50.0% |
| Q4 2017 | $1,811,000 | +31.6% | 26,234 | +73.3% | 0.00% | +100.0% |
| Q3 2017 | $1,376,000 | +40.1% | 15,139 | +14.8% | 0.00% | 0.0% |
| Q2 2017 | $982,000 | +8.6% | 13,187 | +36.6% | 0.00% | 0.0% |
| Q1 2017 | $904,000 | +121.6% | 9,653 | +79.7% | 0.00% | – |
| Q4 2016 | $408,000 | -18.2% | 5,372 | +12.4% | 0.00% | -100.0% |
| Q3 2016 | $499,000 | +45.1% | 4,781 | +2.4% | 0.00% | – |
| Q2 2016 | $344,000 | +41.6% | 4,670 | +7.9% | 0.00% | – |
| Q1 2016 | $243,000 | -34.7% | 4,328 | -21.6% | 0.00% | – |
| Q4 2015 | $372,000 | – | 5,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |